Update on the Vamorolone Program
We will provide an update on the scientific rationale for use of vamorolone, and share some results from our open-label Long Term Extension study. The very important pivotal clinical trial is now seeking participants; we will review information about this trial. ReveraGen was recently awarded a grant to study family and physician preferences regarding the return of individual and aggregate clinical trial data to participant families. Finally, we will discuss ReveraGen’s unique funding model.
Click here to watch the recording of the webinar. You’ll be prompted to enter your name and email address to view the recording.